[1]
Sacharczuk, W. et al. 2022. First signs of reverse cardiac remodeling following one-month, low dose add-on sacubitril-valsartan therapy in patients with advanced systolic heart failure. Journal of Medical Science. 91, 1 (Mar. 2022), e606. DOI:https://doi.org/10.20883/medical.e606.